{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T01:53:39Z","timestamp":1770688419478,"version":"3.49.0"},"reference-count":34,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"DOI":"10.3201\/eid1712.110607","type":"journal-article","created":{"date-parts":[[2011,12,7]],"date-time":"2011-12-07T20:58:18Z","timestamp":1323291498000},"page":"2262-2269","source":"Crossref","is-referenced-by-count":13,"title":["Candidate Cell Substrates, Vaccine Production, and Transmissible Spongiform Encephalopathies"],"prefix":"10.3201","volume":"17","author":[{"given":"Pedro","family":"Piccardo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larisa","family":"Cervenakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Vasilyeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oksana","family":"Yakovleva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Bacik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juraj","family":"Cervenak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carroll","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubica","family":"Kurillova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Gregori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kitty","family":"Pomeroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Asher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","published-online":{"date-parts":[[2011,12]]},"reference":[{"key":"key-10.3201\/eid1712.110607-201112070500-R1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1126\/science.6801762","article-title":"Novel proteinaceous infectious particles cause scrapie.","volume":"216","author":"Prusiner","year":"1982","journal-title":"Science"},{"key":"key-10.3201\/eid1712.110607-201112070500-R2","first-page":"103","article-title":"The transmissible spongiform encephalopathy agents: concerns and responses of United States regulatory agencies in maintaining the safety of biologics","volume":"100","author":"Asher","year":"1999","journal-title":"Dev Biol Stand"},{"key":"key-10.3201\/eid1712.110607-201112070500-R3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0092-8674(03)01031-6","article-title":"Mammalian prion biology: one century of evolving concepts.","volume":"116","author":"Aguzzi","year":"2004","journal-title":"Cell"},{"key":"key-10.3201\/eid1712.110607-201112070500-R4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1423-0410.2006.00833.x","article-title":"Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study.","volume":"91","author":"Hewitt","year":"2006","journal-title":"Vox Sang"},{"key":"key-10.3201\/eid1712.110607-201112070500-R5","unstructured":"UK Health Protection Agency. Fourth case of transfusion-associated variant-CJD infection. Health Protection Report. 2007 [cited 2011 Sep 12]. http:\/\/www.hpa.org.uk\/hpr\/archives\/2007\/news2007\/news0307.htm#cjd"},{"key":"key-10.3201\/eid1712.110607-201112070500-R6","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1365-2516.2009.02181.x","article-title":"Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia.","volume":"16","author":"Peden","year":"2010","journal-title":"Haemophilia"},{"key":"key-10.3201\/eid1712.110607-201112070500-R7","doi-asserted-by":"publisher","first-page":"35878","DOI":"10.1074\/jbc.M704329200","article-title":"High titers of transmissible spongiform encephalopathy infectivity associated with extremely low levels of PrPsc in vivo.","volume":"282","author":"Barron","year":"2007","journal-title":"J Biol Chem"},{"key":"key-10.3201\/eid1712.110607-201112070500-R8","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1073\/pnas.0609241104","article-title":"Accumulation of PrP in the brain that is not associated with transmissible disease.","volume":"104","author":"Piccardo","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid1712.110607-201112070500-R9","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/jcb.21988","article-title":"Strain-specific viral properties of variant Creutzfeldt-Jakob disease (vCJD) are encoded by the agent and not by host prion protein.","volume":"106","author":"Manuelidis","year":"2009","journal-title":"J Cell Biochem"},{"key":"key-10.3201\/eid1712.110607-201112070500-R10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.sbi.2008.12.007","article-title":"Prion protein misfolding and disease.","volume":"19","author":"Moore","year":"2009","journal-title":"Curr Opin Struct Biol"},{"key":"key-10.3201\/eid1712.110607-201112070500-R11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1086\/381166","article-title":"Susceptibility of common fibroblast cell lines to transmissible spongiform, encephalopathy agents.","volume":"189","author":"Vorberg","year":"2004","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1712.110607-201112070500-R12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/261144a0","article-title":"Infection of a cell line of mouse L fibroblasts with scrapie agent.","volume":"261","author":"Clarke","year":"1976","journal-title":"Nature"},{"key":"key-10.3201\/eid1712.110607-201112070500-R13","unstructured":"Cashman NR. Transmissible spongiform encephalopathies: vaccine issues. In: Brown F, Lewis AM jr, Peden K, Krause P, editors. Evolving scientific and regulatory perspectives on cell subtrates for vaccine development. Basel (Switzerland): Karger; 2001."},{"key":"key-10.3201\/eid1712.110607-201112070500-R14","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1046\/j.0041-1132.2003.00586.x","article-title":"Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy.","volume":"43","author":"Cervenakova","year":"2003","journal-title":"Transfusion"},{"key":"key-10.3201\/eid1712.110607-201112070500-R15","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1046\/j.1537-2995.1998.38998408999.x","article-title":"The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy.","volume":"38","author":"Brown","year":"1998","journal-title":"Transfusion"},{"key":"key-10.3201\/eid1712.110607-201112070500-R16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0140-6736(04)16812-8","article-title":"Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood.","volume":"364","author":"Gregori","year":"2004","journal-title":"Lancet"},{"key":"key-10.3201\/eid1712.110607-201112070500-R17","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1099\/0022-1317-83-11-2897","article-title":"Transmission of prion diseases by blood transfusion.","volume":"83","author":"Hunter","year":"2002","journal-title":"J Gen Virol"},{"key":"key-10.3201\/eid1712.110607-201112070500-R18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/00003226-199901000-00002","article-title":"Risk of prion disease transmission from ocular donor tissue transplantation.","volume":"18","author":"Hogan","year":"1999","journal-title":"Cornea"},{"key":"key-10.3201\/eid1712.110607-201112070500-R19","unstructured":"Food and Drug Administration. Bovine derived materials used in vaccine manufacturing questions and answers. Last updated June 18, 2009 [cited 2011 Sep 12]. http:\/\/www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/QuestionsaboutVaccines\/ucm143521.htm"},{"key":"key-10.3201\/eid1712.110607-201112070500-R20","unstructured":"Centers for Disease Control and Prevention. BSE (bovine spongiform encephalopathy, or mad cow disease). Last updated March 17, 2011 [cited 2011 Sep 12]. http:\/\/www.cdc.gov\/ncidod\/dvrd\/bse\/"},{"key":"key-10.3201\/eid1712.110607-201112070500-R21","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1099\/vir.0.79959-0","article-title":"Standards for the assay of Creutzfeldt-Jakob disease specimens.","volume":"85","author":"Minor","year":"2004","journal-title":"J Gen Virol"},{"key":"key-10.3201\/eid1712.110607-201112070500-R22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcpa.2011.09.004","article-title":"Squirrel monkeys (Saimiri sciureaus) infected with the agent of bovine spongiform encephalopathy develop tau pathology.","author":"Piccardo","year":"2011","journal-title":"J Comp Pathol"},{"key":"key-10.3201\/eid1712.110607-201112070500-R23","doi-asserted-by":"publisher","first-page":"29218","DOI":"10.1074\/jbc.M402576200","article-title":"Acute formation of protease-resistant prion protein does not always lead to persistent scrapie infection in vitro.","volume":"279","author":"Vorberg","year":"2004","journal-title":"J Biol Chem"},{"key":"key-10.3201\/eid1712.110607-201112070500-R24","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1016\/j.vaccine.2008.03.035","article-title":"Canine MDCK cell lines are refractory to infection with human and mouse prions.","volume":"26","author":"Polymenidou","year":"2008","journal-title":"Vaccine"},{"key":"key-10.3201\/eid1712.110607-201112070500-R25","unstructured":"National Biological Standards Board. NBSB annual report and accounts. 2004 [cited 2011 Sep 12]. http:\/\/www.nibsc.ac.uk\/PDF\/NBSB_annual_report_200304.pdf"},{"key":"key-10.3201\/eid1712.110607-201112070500-R26","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1128\/JVI.74.9.4377-4386.2000","article-title":"Cultured cell sublines highly susceptible to prion infection.","volume":"74","author":"Bosque","year":"2000","journal-title":"J Virol"},{"key":"key-10.3201\/eid1712.110607-201112070500-R27","doi-asserted-by":"publisher","first-page":"20908","DOI":"10.1073\/pnas.0710054104","article-title":"Prion strain discrimination in cell culture: the cell panel assay.","volume":"104","author":"Mahal","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid1712.110607-201112070500-R28","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1073\/pnas.0610999104","article-title":"Cells infected with scrapie and Creutzfeldt-Jakob disease agents produce intracellular 25-nm virus-like particles.","volume":"104","author":"Manuelidis","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.3201\/eid1712.110607-201112070500-R29","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1099\/0022-1317-65-12-2191","article-title":"In vitro replication of scrapie agent in a neuronal model: infection of PC12 cells.","volume":"65","author":"Rubenstein","year":"1984","journal-title":"J Gen Virol"},{"key":"key-10.3201\/eid1712.110607-201112070500-R30","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1111\/j.1537-2995.2010.03041.x","article-title":"Fukuoka-1 strain of transmissible spongiform encephalopathy agent infects murine bone marrow-derived cells with features of mesenchymal stem cells.","volume":"51","author":"Cervenakova","year":"2011","journal-title":"Transfusion"},{"key":"key-10.3201\/eid1712.110607-201112070500-R31","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1136\/vr.121.18.419","article-title":"A novel progressive spongiform encephalopathy in cattle.","volume":"121","author":"Wells","year":"1987","journal-title":"Vet Rec"},{"key":"key-10.3201\/eid1712.110607-201112070500-R32","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1098\/rstb.1994.0036","article-title":"Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and species barrier","volume":"343","author":"Bruce","year":"1994","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"key-10.3201\/eid1712.110607-201112070500-R33","first-page":"9","article-title":"Gibbs CJJr, Sulima MP, Bacote A, Amyx H, Gajdusek DC. Transmission of human spongiform encephalopathies to experimental animals: comparison of the chimpanzee and squirrel monkey.","volume":"80","author":"Asher","year":"1993","journal-title":"Dev Biol Stand"},{"key":"key-10.3201\/eid1712.110607-201112070500-R34","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1128\/JVI.01578-10","article-title":"Increased susceptibility of human-PrP transgenic mice to bovine spongiform encephalopathy following passage in sheep.","volume":"85","author":"Plinston","year":"2011","journal-title":"J Virol"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/17\/12\/11-0607_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T04:10:06Z","timestamp":1733285406000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/17\/12\/11-0607_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":34,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2011,12]]}},"URL":"https:\/\/doi.org\/10.3201\/eid1712.110607","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}